Fundraising FoxDay Zero Diagnostics
Brookline, US · Founded 2016 · 3 known investors
Find your way into Day Zero Diagnostics
Each arrow is one introduction. Sign up to fill in the first one.
Ask Arvin Singh to introduce you to Miriam Huntley
You →Arvin · together at Cepheid →Miriam
Sign up to find every way you can get introduced to Day Zero Diagnostics
- Your email: who you already know at Day Zero Diagnostics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Day Zero Diagnostics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
The page is a bioMérieux blog article about tracking a Cyclospora cayetanensis outbreak in the United States, referencing its clinical diagnostic and wastewater surveillance products for community health and medical professionals.
Founders & leadership
Day Zero Diagnostics was founded in 2016 by Jong Lee, Miriam Huntley, and Douglas Kwon.
Board
Investors · 3
How we know: Golden Seeds's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: a partner's Signal profile · the VCSheet dataset · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$2.5M disclosed across 1 of 5 rounds · 2017–2023
- Undisclosed amountSeries AJan 2019 · 2 sourcesSource ↗
▶$2.5MraisedMay 2017 · 28 investors · BiotechnologyRule 506(b)
- Jong LeeExecutive Officer, Director
- Jeff MirvissDirector
- Miriam HuntleyExecutive Officer
- Dougal MclaurinExecutive Officer
- Laura DavisDirector
- Douglas KwonDirector
- Offering amount
- $3.5M
- Amount sold
- $2.5M
- First sale
- May 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $303.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $224.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Day Zero Diagnostics do?
- The page is a bioMérieux blog article about tracking a Cyclospora cayetanensis outbreak in the United States, referencing its clinical diagnostic and wastewater surveillance products for community health and medical professionals.
- Who founded Day Zero Diagnostics?
- Day Zero Diagnostics was founded by Jong Lee, Miriam Huntley, Douglas Kwon in 2016.
- Who are Day Zero Diagnostics's investors?
- Day Zero Diagnostics's investors include Golden Seeds, Triventures.
- How much funding has Day Zero Diagnostics raised?
- Day Zero Diagnostics has disclosed $2.5M raised across 1 of its 5 known rounds.
- Where is Day Zero Diagnostics headquartered?
- Day Zero Diagnostics is headquartered in Brookline, US.